NM_001061.7:c.689-105C>A

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_001061.7(TBXAS1):​c.689-105C>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0933 in 1,516,642 control chromosomes in the GnomAD database, including 7,759 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.079 ( 712 hom., cov: 31)
Exomes 𝑓: 0.095 ( 7047 hom. )

Consequence

TBXAS1
NM_001061.7 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -2.42

Publications

1 publications found
Variant links:
Genes affected
TBXAS1 (HGNC:11609): (thromboxane A synthase 1) This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. However, this protein is considered a member of the cytochrome P450 superfamily on the basis of sequence similarity rather than functional similarity. This endoplasmic reticulum membrane protein catalyzes the conversion of prostglandin H2 to thromboxane A2, a potent vasoconstrictor and inducer of platelet aggregation. The enzyme plays a role in several pathophysiological processes including hemostasis, cardiovascular disease, and stroke. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Aug 2008]
TBXAS1 Gene-Disease associations (from GenCC):
  • ghosal hematodiaphyseal dysplasia
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: ClinGen, Labcorp Genetics (formerly Invitae), G2P, Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.82).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.207 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TBXAS1NM_001061.7 linkc.689-105C>A intron_variant Intron 7 of 12 ENST00000448866.7 NP_001052.3 P24557-1Q53F23

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TBXAS1ENST00000448866.7 linkc.689-105C>A intron_variant Intron 7 of 12 1 NM_001061.7 ENSP00000402536.3 P24557-1

Frequencies

GnomAD3 genomes
AF:
0.0792
AC:
12044
AN:
152030
Hom.:
712
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.0184
Gnomad AMI
AF:
0.0384
Gnomad AMR
AF:
0.0556
Gnomad ASJ
AF:
0.0749
Gnomad EAS
AF:
0.217
Gnomad SAS
AF:
0.0988
Gnomad FIN
AF:
0.194
Gnomad MID
AF:
0.0475
Gnomad NFE
AF:
0.0928
Gnomad OTH
AF:
0.0788
GnomAD4 exome
AF:
0.0949
AC:
129456
AN:
1364494
Hom.:
7047
AF XY:
0.0951
AC XY:
65017
AN XY:
683416
show subpopulations
African (AFR)
AF:
0.0159
AC:
503
AN:
31600
American (AMR)
AF:
0.0351
AC:
1511
AN:
43104
Ashkenazi Jewish (ASJ)
AF:
0.0694
AC:
1753
AN:
25256
East Asian (EAS)
AF:
0.229
AC:
8883
AN:
38760
South Asian (SAS)
AF:
0.0957
AC:
7981
AN:
83430
European-Finnish (FIN)
AF:
0.182
AC:
8269
AN:
45548
Middle Eastern (MID)
AF:
0.0745
AC:
414
AN:
5558
European-Non Finnish (NFE)
AF:
0.0918
AC:
94901
AN:
1034034
Other (OTH)
AF:
0.0916
AC:
5241
AN:
57204
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
5844
11689
17533
23378
29222
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
3404
6808
10212
13616
17020
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0791
AC:
12039
AN:
152148
Hom.:
712
Cov.:
31
AF XY:
0.0844
AC XY:
6274
AN XY:
74360
show subpopulations
African (AFR)
AF:
0.0184
AC:
763
AN:
41552
American (AMR)
AF:
0.0555
AC:
848
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
0.0749
AC:
260
AN:
3470
East Asian (EAS)
AF:
0.218
AC:
1123
AN:
5162
South Asian (SAS)
AF:
0.0985
AC:
474
AN:
4814
European-Finnish (FIN)
AF:
0.194
AC:
2048
AN:
10560
Middle Eastern (MID)
AF:
0.0476
AC:
14
AN:
294
European-Non Finnish (NFE)
AF:
0.0928
AC:
6306
AN:
67980
Other (OTH)
AF:
0.0794
AC:
168
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
523
1046
1570
2093
2616
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
146
292
438
584
730
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0833
Hom.:
86
Bravo
AF:
0.0654
Asia WGS
AF:
0.138
AC:
480
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.82
CADD
Benign
0.016
DANN
Benign
0.57
PhyloP100
-2.4
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3735355; hg19: chr7-139657328; COSMIC: COSV54956691; COSMIC: COSV54956691; API